Board Change

RNS Number:3424D
Bespak PLC
05 November 2002

For Immediate Release                                 07.05 am, 5 November 2002


                                   BESPAK PLC

                                  BOARD CHANGE

Bespak (LSE:BPK), innovator of drug delivery technologies, today announces a
Board change.  Group Finance Director, Robert Preece, steps down from the Bespak
Board, thus crystallising his long-term plans to move on at the end of this
year.  Martin Hopcroft, an external appointment, replaces him with immediate
effect, and will work alongside Robert for the next two months to ensure a
smooth transition period.

Martin Hopcroft (42) brings with him extensive experience with international,
publicly quoted businesses engaged in manufacturing, high-tech engineering and
pharmaceuticals.  He joins from Kvaerner Oil & Gas where he was Group Finance
Director.  Prior to Kvaerner, Martin was Group Finance Director of Darby Group
plc and held senior financial positions at Merial and Halma.  A qualified
chartered accountant with KPMG, Martin is a graduate of the London School of
Economics.

Robert Preece has been Bespak's Group Finance Director since 1995.  During this
time he also served as Acting CEO for a year until the arrival of Mark Throdahl
in June 2001.

Commenting on an exciting new appointment and on the loss of a valued colleague,
Chief Executive Mark Throdahl said:

"This summer Robert told me that when a suitable replacement could be found he
would like to move on.  I am disappointed to lose Robert at this moment of
Bespak's evolution, as both a friend and a colleague, but I respect his desire
to explore other opportunities.  I am particularly grateful for his offer to
stay on until the end of this year so we can effect a seamless transition.

"We welcome Martin and are delighted to have attracted an executive of his
calibre and experience.    Bespak remains committed to the strategy put in place
by Robert during his time on the Board and continues to pursue a number of
exciting opportunities, particularly in the area of nasal drug delivery.  I look
forward to pursuing these with Martin."



                                    - ENDS -



For further information please call:

BESPAK plc
Mark Throdahl - Chief Executive                      TEL: [phone]
Robert Preece - Deputy Chief Executive & 
Group Finance Director

BUCHANAN COMMUNICATIONS                              TEL: [phone]
Tim Thompson / Nicola How



Notes to Editors:

About Bespak plc:

Bespak plc is in the forefront of developing new delivery systems for the
pharmaceutical industry. The company has a product range covering metered dose
inhalers, dry powder inhalers, actuator and spacer systems, as well as
specialist components and assemblies for the US medical device industry.   The
Group has manufacturing facilities in King's Lynn and Milton Keynes in the UK
and in Cary, North Carolina in the USA.

Bespak is quoted on the Full List of the London Stock Exchange.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOABKQKQFBDDNDK